MAPT and Alzheimer disease: HDAC6 inhibitors rescue cognitive dysfunction [37], restore microtubule-dependent axonal transport [38], and attenuate Tau-induced neurodegeneration [39] in AD mouse models by increasing the acetylation of tubulin [24] and Tau [40].